A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath ...
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath ...
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.
A significant proportion of patients developed exocrine pancreatic insufficiency 12 months after a diagnosis of acute ...
Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe ...
Financial writer rates Mereo BioPharma stock as Hold despite recent positive data, citing uncertainties around Phase 3 ...
The Peak Bio pipeline includes an antibody-drug-conjugate (ADC) platform that includes novel toxins and linkers coupled with important cancer antibody targets and a Phase 2-ready neutrophil elastase ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases ...